Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.02% vs -4.20% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -29.27% vs -70.83% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -18.03% vs -25.61% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -38.10% vs 10.53% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Rekah Pharmaceutical Industry Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.02% vs -4.20% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -13.88% vs 9.00% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -29.27% vs -70.83% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -12.77% vs 14.55% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -18.03% vs -25.61% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 19.05% vs -32.26% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -38.10% vs 10.53% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -43.48% vs -4.17% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






